219
Sutro Biopharma Inc.
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
Assets
(positive)
Change from FY21 to FY25
millions USD
FY21:
FY22:
353
FY23:
422
FY24:
343
FY25:
151
(positive)
Change from FY21 to FY25
millions USD
FY21:
123
FY22:
53.8
FY23:
49.2
FY24:
43.9
FY25:
22.9
Total assets
Change from FY21 to FY25
millions USD
FY21:
341
FY22:
407
FY23:
471
FY24:
387
FY25:
174
Liabilities & Equity
(negative)
Change from FY21 to FY25
millions USD
FY21:
41.7
FY22:
66.5
FY23:
93.7
FY24:
132
FY25:
75.1
(negative)
Change from FY21 to FY25
millions USD
FY21:
47.1
FY22:
123
FY23:
227
FY24:
211
FY25:
231
(positive)
Change from FY21 to FY25
millions USD
FY21:
253
FY22:
217
FY23:
150
FY24:
44.6
FY25:
−132
Total liabilities & equity
Change from FY21 to FY25
millions USD
FY21:
341
FY22:
407
FY23:
471
FY24:
387
FY25:
174
All amounts in millions USD